Naturex’s full-year sales rose 7% amid natural and health trends, despite the difficult global economic conditions prevailing in 2013 which led to slower economic growth, particularly in Western Europe.
Full-year sales reached €320.8 million, up 7% from 2012. At constant exchange rates, sales rose 9.7% including organic growth of 8% and 1.7% from changes in group structure (business of Decas Botanical Synergies consolidated as of Sept. 19, 2012).
By segment, food and beverage had revenue of €184.1 million, with a marginal gain at constant exchange rates from the same period in 2012. Nutrition and health sales rose 24.8% at constant exchange rates to reach €112.9 million for the year, reflecting both Naturex's strong positioning in North America as well as significant development in Europe, Asia and Latin America. Personal Care had revenue of nearly €6 million, up 24% at constant exchange rates.
Growth performances for the three geographical regions were less uneven, despite currency effects, due to positive contributions from emerging countries that account for 17.7% of group sales. The Europe/Africa region had revenue of €150.6 million, up 6.9% at constant exchange rates from 2012.
Selected Western European countries showed encouraging signs of recovery at year-end. Revenue for the Americas region rose 11.4% at constant exchange rates to €130.3 million, with the strong contribution of the United States and Latin America's continuing strength despite the significant depreciation of selected currencies, in particular the Brazilian real.
The Asia/Pacific region had growth of 14.7% at constant exchange rates with revenue of €39.9 million. Asia continued to show very strong gains and now accounts for 53.5% of sales for this region, whereas sales in Australia advanced at a slower pace.
